934 related articles for article (PubMed ID: 24211078)
21. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications.
Singh SK; Singh MK; Kulkarni PP; Sonkar VK; Grácio JJ; Dash D
ACS Nano; 2012 Mar; 6(3):2731-40. PubMed ID: 22376049
[TBL] [Abstract][Full Text] [Related]
22. Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells.
Russier J; Treossi E; Scarsi A; Perrozzi F; Dumortier H; Ottaviano L; Meneghetti M; Palermo V; Bianco A
Nanoscale; 2013 Nov; 5(22):11234-47. PubMed ID: 24084792
[TBL] [Abstract][Full Text] [Related]
23. No cytotoxicity or genotoxicity of graphene and graphene oxide in murine lung epithelial FE1 cells in vitro.
Bengtson S; Kling K; Madsen AM; Noergaard AW; Jacobsen NR; Clausen PA; Alonso B; Pesquera A; Zurutuza A; Ramos R; Okuno H; Dijon J; Wallin H; Vogel U
Environ Mol Mutagen; 2016 Jul; 57(6):469-82. PubMed ID: 27189646
[TBL] [Abstract][Full Text] [Related]
24. In vitro toxicity evaluation of graphene oxide on A549 cells.
Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the toxicity of graphene oxide exposure to the eye.
Wu W; Yan L; Wu Q; Li Y; Li Q; Chen S; Yang Y; Gu Z; Xu H; Yin ZQ
Nanotoxicology; 2016 Nov; 10(9):1329-40. PubMed ID: 27385068
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of polymer-protected graphene by solvent-assisted thermal reduction process.
Zhang Y; Hu W; Li B; Peng C; Fan C; Huang Q
Nanotechnology; 2011 Aug; 22(34):345601. PubMed ID: 21795771
[TBL] [Abstract][Full Text] [Related]
27. Selective Accelerated Proliferation of Malignant Breast Cancer Cells on Planar Graphene Oxide Films.
Kenry ; Chaudhuri PK; Loh KP; Lim CT
ACS Nano; 2016 Mar; 10(3):3424-34. PubMed ID: 26919537
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
29. Hemin-functionalized reduced graphene oxide nanosheets reveal peroxynitrite reduction and isomerization activity.
Vernekar AA; Mugesh G
Chemistry; 2012 Nov; 18(47):15122-32. PubMed ID: 23042238
[TBL] [Abstract][Full Text] [Related]
30. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene.
Sasidharan A; Panchakarla LS; Chandran P; Menon D; Nair S; Rao CN; Koyakutty M
Nanoscale; 2011 Jun; 3(6):2461-4. PubMed ID: 21562671
[TBL] [Abstract][Full Text] [Related]
31. Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
Kiew SF; Kiew LV; Lee HB; Imae T; Chung LY
J Control Release; 2016 Mar; 226():217-28. PubMed ID: 26873333
[TBL] [Abstract][Full Text] [Related]
32. Silver-doped graphene oxide nanocomposite triggers cytotoxicity and apoptosis in human hepatic normal and carcinoma cells.
Ali D; Alarifi S; Alkahtani S; Almeer RS
Int J Nanomedicine; 2018; 13():5685-5699. PubMed ID: 30288041
[TBL] [Abstract][Full Text] [Related]
33. In vitro hemocompatibility and toxic mechanism of graphene oxide on human peripheral blood T lymphocytes and serum albumin.
Ding Z; Zhang Z; Ma H; Chen Y
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19797-807. PubMed ID: 25371999
[TBL] [Abstract][Full Text] [Related]
34. In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells.
Tabish TA; Pranjol MZI; Hayat H; Rahat AAM; Abdullah TM; Whatmore JL; Zhang S
Nanotechnology; 2017 Dec; 28(50):504001. PubMed ID: 29064374
[TBL] [Abstract][Full Text] [Related]
35. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Int J Nanomedicine; 2013; 8():1015-27. PubMed ID: 23687445
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the underlying mechanisms of oxidation-state dependent cytotoxicity of graphene oxide on mammalian cells.
Zhang W; Yan L; Li M; Zhao R; Yang X; Ji T; Gu Z; Yin JJ; Gao X; Nie G
Toxicol Lett; 2015 Sep; 237(2):61-71. PubMed ID: 26047786
[TBL] [Abstract][Full Text] [Related]
37. Hydration patterns of graphene-based nanomaterials (GBNMs) play a major role in the stability of a helical protein: a molecular dynamics simulation study.
Baweja L; Balamurugan K; Subramanian V; Dhawan A
Langmuir; 2013 Nov; 29(46):14230-8. PubMed ID: 24144078
[TBL] [Abstract][Full Text] [Related]
38. Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial.
Zhang XF; Gurunathan S
Int J Nanomedicine; 2016; 11():6635-6649. PubMed ID: 27994461
[TBL] [Abstract][Full Text] [Related]
39. Concentration- and time-dependence toxicity of graphene oxide (GO) and reduced graphene oxide (rGO) nanosheets upon zebrafish liver cell line.
Siqueira PR; Souza JP; Estevão BM; Altei WF; Carmo TLL; Santos FA; Araújo HSS; Zucolotto V; Fernandes MN
Aquat Toxicol; 2022 Jul; 248():106199. PubMed ID: 35613511
[TBL] [Abstract][Full Text] [Related]
40. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Dudek I; Skoda M; Jarosz A; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):195-215. PubMed ID: 26502273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
